BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32958754)

  • 1. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of G
    Abboud D; Daly AF; Dupuis N; Bahri MA; Inoue A; Chevigné A; Ectors F; Plenevaux A; Pirotte B; Beckers A; Hanson J
    Nat Commun; 2020 Sep; 11(1):4752. PubMed ID: 32958754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gigantism: X-linked acrogigantism and GPR101 mutations.
    Iacovazzo D; Korbonits M
    Growth Horm IGF Res; 2016; 30-31():64-69. PubMed ID: 27743704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for genetic causes of growth hormone hypersecretion.
    Rostomyan L; Beckers A
    Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations.
    Trivellin G; Hernández-Ramírez LC; Swan J; Stratakis CA
    Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):125-140. PubMed ID: 29678281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
    Iacovazzo D; Caswell R; Bunce B; Jose S; Yuan B; Hernández-Ramírez LC; Kapur S; Caimari F; Evanson J; Ferraù F; Dang MN; Gabrovska P; Larkin SJ; Ansorge O; Rodd C; Vance ML; Ramírez-Renteria C; Mercado M; Goldstone AP; Buchfelder M; Burren CP; Gurlek A; Dutta P; Choong CS; Cheetham T; Trivellin G; Stratakis CA; Lopes MB; Grossman AB; Trouillas J; Lupski JR; Ellard S; Sampson JR; Roncaroli F; Korbonits M
    Acta Neuropathol Commun; 2016 Jun; 4(1):56. PubMed ID: 27245663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism.
    Franke M; Daly AF; Palmeira L; Tirosh A; Stigliano A; Trifan E; Faucz FR; Abboud D; Petrossians P; Tena JJ; Vitali E; Lania AG; Gómez-Skarmeta JL; Beckers A; Stratakis CA; Trivellin G
    Am J Hum Genet; 2022 Apr; 109(4):553-570. PubMed ID: 35202564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR101: Modeling a constitutively active receptor linked to X-linked acrogigantism.
    Costanzi S; Stahr LG; Trivellin G; Stratakis CA
    J Mol Graph Model; 2024 Mar; 127():108676. PubMed ID: 38006624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism.
    Caruso M; Mazzatenta D; Asioli S; Costanza G; Trivellin G; Franke M; Abboud D; Hanson J; Raverot V; Pétrossians P; Beckers A; Cappa M; Daly AF
    Front Endocrinol (Lausanne); 2024; 15():1345363. PubMed ID: 38481440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GHRH excess and blockade in X-LAG syndrome.
    Daly AF; Lysy PA; Desfilles C; Rostomyan L; Mohamed A; Caberg JH; Raverot V; Castermans E; Marbaix E; Maiter D; Brunelle C; Trivellin G; Stratakis CA; Bours V; Raftopoulos C; Beauloye V; Barlier A; Beckers A
    Endocr Relat Cancer; 2016 Mar; 23(3):161-70. PubMed ID: 26671997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
    Trivellin G; Daly AF; Faucz FR; Yuan B; Rostomyan L; Larco DO; Schernthaner-Reiter MH; Szarek E; Leal LF; Caberg JH; Castermans E; Villa C; Dimopoulos A; Chittiboina P; Xekouki P; Shah N; Metzger D; Lysy PA; Ferrante E; Strebkova N; Mazerkina N; Zatelli MC; Lodish M; Horvath A; de Alexandre RB; Manning AD; Levy I; Keil MF; Sierra Mde L; Palmeira L; Coppieters W; Georges M; Naves LA; Jamar M; Bours V; Wu TJ; Choong CS; Bertherat J; Chanson P; Kamenický P; Farrell WE; Barlier A; Quezado M; Bjelobaba I; Stojilkovic SS; Wess J; Costanzi S; Liu P; Lupski JR; Beckers A; Stratakis CA
    N Engl J Med; 2014 Dec; 371(25):2363-74. PubMed ID: 25470569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
    Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
    J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in GPR101 as a potential cause of X-linked acrogigantism and acromegaly.
    Hou ZS; Tao YX
    Prog Mol Biol Transl Sci; 2019; 161():47-67. PubMed ID: 30711029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism.
    Daly AF; Beckers A
    Endocr Rev; 2024 May; ():. PubMed ID: 38696651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
    Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
    Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
    Pepe S; Korbonits M; Iacovazzo D
    J Endocrinol; 2019 Feb; 240(2):R21-R45. PubMed ID: 30530903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency.
    Castinetti F; Daly AF; Stratakis CA; Caberg JH; Castermans E; Trivellin G; Rostomyan L; Saveanu A; Jullien N; Reynaud R; Barlier A; Bours V; Brue T; Beckers A
    Horm Metab Res; 2016 Jun; 48(6):389-93. PubMed ID: 26797872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA).
    Vasilev V; Daly AF; Trivellin G; Stratakis CA; Zacharieva S; Beckers A
    Endocr Relat Cancer; 2020 Aug; 27(8):T77-T86. PubMed ID: 32083999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The X-linked acrogigantism-associated gene gpr101 is a regulator of early embryonic development and growth in zebrafish.
    Trivellin G; Tirosh A; Hernández-Ramírez LC; Gupta T; Tsai-Morris CH; Faucz FR; Burgess HA; Feldman B; Stratakis CA
    Mol Cell Endocrinol; 2021 Jan; 520():111091. PubMed ID: 33248229
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.